Dr Reddys

Dr Reddy's Laboratories announced today that it has launched Amoxicillin Tablets Capsules, and Oral Suspension, a bioequivalent generic version of Amoxil® (Amoxicillin) Tablets, Capsules, and Oral Suspension in the US Market on September 17, 2012. Amoxicillin Tablets (500 mg and 875 mg), Capsules (250 mg and 500 mg), and Oral Suspension (125 mg/5 ml, 200 mg/5 ml, 250 mg/5 ml, and 400 mg/5 ml) are approved by the United States Food and Drug Administration (USFDA).

The Amoxil brand and generic Tablets (875 mg) has U.S. sales of approximately $22.2 million, Capsules has U.S. sales of approximately $67.2 million, and Oral Suspension has U.S. sales of approximately $89.5 million, all for the most recent twelve months ending June 2012 according to IMS Health.

Dr. Reddy's Amoxicillin Tablets in 500 mg and 875 mg are available in bottle counts of 20 and 100. Amoxiciliin Capsules in 250 mg and 500 mg are available in bottle counts of 100 and 500. Amoxicillin Oral Suspension in 200 mg/5 ml and 400 mg/5 ml are available in bottle sizes of 50 ml, 75 ml, and 100 mi. Amoxicillin Oral Suspension in 125 mg/5 ml and 250 mg/5 ml are avaiiable in bottle sizes of 80 ml, 100 ml, and 150 ml.